Delivery Order SPE2DB24D1021-SPE2DB25FFAVF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Aplenzin ER 348 mg tablets in quantities of 30 units, with a contract ceiling value of $18,556.71. This firm fixed-price delivery order, which is expected to be completed by August 28, 2025, represents a non-set-aside competitively awarded procurement. The award will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $3,789.82 to AmerisourceBergen Drug Corp for the supply of Aplenzin ER 174 mg tablets (30-count packaging) on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,537.34 firm fixed-price delivery order is for the supply of APLENZIN ER 522 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of March 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division,...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,165.95 firm fixed-price delivery order is for the medical product "APLENZIN ER 348 MG TABLET 30S" and has a performance period through May 2, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This is a $9,440.31 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide APLENZIN ER 348 MG TABLET 30S. The contract has an ultimate completion date of May 8, 2023. This order is part of a larger $999,999,999 Indefinite Delivery Contract that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,512.09 firm fixed-price contract is for the delivery of the pharmaceutical product APLENZIN ER 348 MG TABLET 30S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which...
- This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,523.29, is for the delivery of the pharmaceutical product APLENZIN ER 522 MG TABLET 30S. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 19, 2025. It is not associated with a set-aside designation. AmerisourceBergen holds a significant Indefinite...
- This federal contract award, valued at $5,470.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the pharmaceutical product "APLENZIN ER 174 MG TABLET 30S" and has a Firm Fixed Price pricing type with an ultimate completion date of October 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) by the prime contractor, Amerisourcebergen Drug Corp. The award, valued at $30,245.89, is a delivery order contract for the supply of the medication APLENZIN ER 522 MG TABLET 30S. The contract has an ultimate completion date of November 22, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $24,463.46 by the Defense Logistics Agency's Medical Supply Chain on September 24, 2025. The award, which has no set-aside designation, is expected to be completed by September 25, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFAVFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,458.54 to AmerisourceBergen Drug Corp for the supply of Aplenzin ER 348 mg tablets (30-count package) on September 17, 2025, with completion targeted for September 18, 2025. This non-competitive delivery order was issued on a firm fixed-price basis and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This delivery order derives from AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor and critical vendor for federal medical procurement, supplies an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The firm fixed-price delivery order model and AmerisourceBergen's established track record of fulfilling federal medical supply requirements across multiple therapeutic domains position the company as a key supplier within the DLA's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 9/17/25 |